Brinzolamide
AZOPT is a carbonic anhydrase inhibitor indicated in the treatment of elevated intraocular pressure (IOP) in patients with ocular hypertension or open-angle glaucoma.
United States
$438
per month
India
$42
per month
You save
−90%save $396/mo · 90% cheaper
223.7K US scripts/yr$88.6M potential annual savings$98M US spend/yr
Drag to rotate · 3D structureC12H21N3O5S3
SMILES: CCN[C@H]1CN(S(=O)(=O)C2=C1C=C(S2)S(=O)(=O)N)CCCOC
Compare the price
US price$438per month
India price$42per month
You save$39690% less
Based on 30 units per month. US $14.61 vs India $1.41 per unit.
Total over 1 periodSave $396$438 → $42
The bigger picture
Brinzolamide is filled about 223.7K times a year under Medicare Part D. At the prices above, that works out to roughly:
Est. annual US spend
$98M
If sourced from India
$9.5M
Potential annual savings
$88.6M
−90%
Rough estimate. Based on Medicare Part D prescription volume (not the entire US market) scaled by the representative monthly price — actual totals depend on dose, duration and coverage.